Industry Context — Common BS Fingerprints in Medical Devices, Pharma & Biotech
Cordis
(https://cordis.com) 📸 Data Snapshot: May 26, 2026Analyze the raw signals below. How would a machine score this business’s credibility?
Here are the exact signals captured from up to six pages of the site — the same raw inputs the evaluation engine analyzed. They are grouped by signal type so you can weigh each the way the machine does.
🏗️ Semantic Structure — heading hierarchy & page identity (Info Density · Commodity Fingerprint)
HOMEPAGE Welcome to Cordis (https://cordis.com)
Welcome to Cordis
Cordis is a global leader in delivering innovative, differentiated cardiovascular and endovascular devices. For over 60 years, we’ve pioneered products.
HEADING_REPEATED_BODY Cordis | Home (https://cordis.com/emea/home/)
Cordis | Home
Innovating and Delivering New Technologies Cordis is proud to have completed the acquisition of MedAlliance and its novel SELUTION SLR™ Drug-Eluting…
HEADING_REPEATED_BODY Cordis | Home (https://cordis.com/latam/home/)
Cordis | Home
Innovating and Delivering New Technologies Cordis is proud to have completed the acquisition of MedAlliance and its novel SELUTION SLR™ Drug-Eluting…
HEADING_REPEATED_BODY Cordis | Home (https://cordis.com/apac/home/)
Cordis | Home
Highlights RAIN Sheath™ Transradial Thin-walled Introducer The RAIN Sheath™ Transradial Thin-walled Introducer introduces innovation in your hands with…
📝 The Narrative — clean text per page (Info Density · Semantic Coherence)
HOMEPAGE (https://cordis.com) Welcome to Cordis
[H1] Welcome to Cordis Please select your country to continue. [H3] Or select country [H3] A Afghanistan Albania Algeria Angola Anguilla Antarctica Antigua Argentina Armenia Aruba Australia Austria Azerbaijan [H3] B Bahamas Bahrain Barbados Belarus Belgium Belize Benin Bermuda Bolivia Bosnia Botswana Brazil British Virgin Islands Bulgaria Burkina Faso Burundi [H3] C Cameroon Canada Cayman Islands Central African Republic Chad Chile China Colombia Congo Costa Rica Croatia Cuba Cyprus Czechia [H3] D Denmark Djibouti Dominica Dominican Republic [H3] E Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia [H3] F Finland France French Polynesia [H3] G Gabon Georgia Germany Ghana Greece Greenland Guadeloupe Guatemala Guinea Guyana [H3] H Haiti Honduras Hungary [H3] I Iceland India Indonesia Iran Iraq Ireland Israel Italy [H3] J Jamaica Japan Jordan [H3] K Kazakhstan Kenya Kuwait Kyrgyzstan [H3] L Latvia Lebanon Liberia Libya Liechtenstein Lithuania Luxembourg [H3] M Madagascar Malawi Mali Malta Martinique Mauritania Mexico Moldova Monaco Montenegro Morocco Mozambique [H3] N Namibia Netherlands New Zealand Nicaragua Niger Nigeria North Macedonia Northern Mariana Islands Norway [H3] O Oman [H3] P Pakistan Palestine Panama Papua New Guinea Paraguay Peru Poland Portugal Puerto Rico [H3] Q Qatar [H3] R Romania Russia Rwanda [H3] S Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Slovakia Slovenia Somalia South Africa South Korea South Sudan Spain Sri Lanka Sudan Suriname Swaziland Sweden Switzerland Syria [H3] T Tajikistan Tanzania Thailand The Gambia Togo Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands [H3] U Uganda Ukraine United Arab Emirates United Kingdom United States Uruguay Uzbekistan [H3] V Venezuela Virgin Islands US [H3] Y Yemen [H3] Z Zambia Zimbabwe
SUB-PAGE (https://cordis.com/emea/home/) Cordis | Home
[H2] Innovating and Delivering New Technologies Cordis is proud to have completed the acquisition of MedAlliance and its novel SELUTION SLR™ Drug-Eluting Balloon (DEB). Using breakthrough proprietary technology, MedAlliance has found a unique solution to the challenge of controlled and sustained sirolimus release with the SELUTION SLR™ DEB. Cordis and MedAlliance combined are committed to accelerating the development and commercialization of innovative cardiovascular interventional products around the world. The SELUTION SLRTM Drug-Eluting Balloon is not approved for sale in every country. Please contact your local representative for additional information Discover More About SELUTION SLR DEB Highlights [H2] SELUTION SLR PTCA Drug Eluting Balloon The SELUTION SLR™ Drug Eluting Balloon (DEB) is the latest generation of drug-eluting balloon technology designed to Go Beyond Metal and deliver consistent and predictable drug release as best-in-class drug-eluting stents Discover More [H2] RAIN Sheath Transradial Thin-walled Introducer The RAIN Sheath™ Transradial Thin-walled Introducer brings innovation in your hands with KINK RECOVERY TECHNOLOGY™. The proprietary sheath with elastomeric properties is designed to maintain lumen integrity. Discover More [H2] MYNX CONTROL Vascular Closure Device Closes with security. Leave nothing behind*. MYNX CONTROL™ Vascular Closure Devices integrate dual-mode active sealing and resorbability with a next-generation delivery system to maximize predictability, safety and ease of use.* The sealant is resorbed by the body within 30 days Discover More Pause [H2] Driven by mission, guided by values Cordis is making a difference. We impact millions of lives, in more than 60 countries around the world. We embrace a diverse, empowered culture where teammates are inspired to serve customers, patients and shareholders while fulfilling their own career aspirations. [H2] Need Help? We’re here with the support and information to help you make the right choices for your patients.
SUB-PAGE (https://cordis.com/latam/home/) Cordis | Home
[H2] Innovating and Delivering New Technologies Cordis is proud to have completed the acquisition of MedAlliance and its novel SELUTION SLR™ Drug-Eluting Balloon (DEB). Using breakthrough proprietary technology, MedAlliance has found a unique solution to the challenge of controlled and sustained sirolimus release with the SELUTION SLR™ DEB. Cordis and MedAlliance combined are committed to accelerating the development and commercialization of innovative cardiovascular interventional products around the world. The SELUTION SLRTM Drug-Eluting Balloon is not approved for sale in every country. Please contact your local representative for additional information Drug Eluting Balloons Clinical Trials Highlights [H2] RAIN Sheath™ Transradial Thin-walled Introducer The RAIN Sheath Transradial Thin-walled Introducer introduces innovation in your hands with KINK RECOVERY TECHNOLOGY™. The proprietary sheath with elastomeric properties is designed to maintain lumen integrity. [H2] RAILWAY™ Sheathless Access System The RAILWAY Sheathless Access System is a versatile system for reducing access up to 2F1. This system features a smaller access profile than any radial sheath, and compatibility with a variety of guiding catheters.1 Compared to conventional radial sheaths. Profile reduction is 1.2F compared to Terumo Glidesheath Slender. [H2] MYNX CONTROL™ Vascular Closure Device Close with confidence. Leave nothing behind. MYNX CONTROL Vascular Closure Devices integrate dual-mode active sealing and resorbability with a next-generation delivery system to maximize predictability, safety, and ease of use. Pause Apr 28, 2026 [H3] SELUTION SLR PTA Drug-Eluting Balloon in Japan Cordis Launches SELUTION SLR™ PTA Drug-Eluting Balloon (DEB) in Japan Read more Mar 17, 2026 [H3] State of Florida and Cordis Announce Planned Investment State of Florida and Cordis Announce Planned Investment and Job Growth in Miami Lakes, FL Read more Mar 4, 2026 [H3] Cordis to Present SELUTION SLR ™ DEB Clinical Data at CRT 2026 Presentations Include 12-Month Outcomes from the SELUTION4ISR Trial and the SELUTION DeNovo Trial in Coronary Lesions, Alongside Analyses on How Procedural Experience Influences Treatment Strategy. Read more [H2] Need Help? We’re here with the support and information to help you make the right decision for your patients.
SUB-PAGE (https://cordis.com/apac/home/) Cordis | Home
Highlights [H2] RAIN Sheath™ Transradial Thin-walled Introducer The RAIN Sheath™ Transradial Thin-walled Introducer introduces innovation in your hands with KINK RECOVERY TECHNOLOGY™. The proprietary sheath with elastomeric properties is designed to maintain lumen integrity. [H2] MYNX CONTROL™ Vascular Closure Device Close with confidence. Leave nothing behind. MYNX CONTROL™Vascular Closure Devices integrate dual-mode active sealing and resorbability with a next-generation delivery system to maximize predictability, safety, and ease of use. [H2] BRITE TIP™ Guiding Catheter The guiding catheter that gives you the confidence and support even in the most challenging cases. Pause Apr 28, 2026 [H3] SELUTION SLR PTA Drug-Eluting Balloon in Japan Cordis Launches SELUTION SLR™ PTA Drug-Eluting Balloon (DEB) in Japan Read more Mar 17, 2026 [H3] State of Florida and Cordis Announce Planned Investment State of Florida and Cordis Announce Planned Investment and Job Growth in Miami Lakes, FL Read more Mar 4, 2026 [H3] Cordis to Present SELUTION SLR ™ DEB Clinical Data at CRT 2026 Presentations Include 12-Month Outcomes from the SELUTION4ISR Trial and the SELUTION DeNovo Trial in Coronary Lesions, Alongside Analyses on How Procedural Experience Influences Treatment Strategy. Read more [H2] Need Help? We’re here with the support and information to help you make the right decision for your patients.
🛡️ Trust Signals — reviews, proof links, trust-theatre flag (Trust & Proof)
| Page | Reviews | Proof links |
|---|---|---|
| / (home) | 0 | 0 |
| /emea/home/ | 1 | 0 |
| /latam/home/ | 1 | 0 |
| /apac/home/ | 0 | 0 |
🔗 Identity & Technical Layer — schema JSON-LD: identity chains, entity gaps (Identity & Authority)
Homepage schema
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebSite",
"author": {
"@id": "https://cordis.com#identity"
},
"copyrightHolder": {
"@id": "https://cordis.com#identity"
},
"copyrightYear": "2021",
"creator": {
"@id": "#creator"
},
"dateCreated": "2021-12-02T06:19:30-08:00",
"dateModified": "2026-05-16T03:10:32-07:00",
"datePublished": "2021-12-02T06:22:00-08:00",
"description": "Cordis is a global leader in delivering innovative, differentiated cardiovascular and endovascular devices. For over 60 years, we’ve pioneered products.",
"headline": "Welcome to Cordis",
"image": {
"@type": "ImageObject",
"url": "https://cordis.com/uploads/images/Cordis-Logos/_1200x630_crop_center-center_82_none/Cordis_Logo-1.png?mtime=1758835439"
},
"inLanguage": "en-us",
"mainEntityOfPage": "https://cordis.com/na/",
"name": "Cordis",
"publisher": {
"@id": "#creator"
},
"url": "https://cordis.com/na"
},
{
"@id": "https://cordis.com#identity",
"@type": "LocalBusiness",
"name": "Cordis",
"priceRange": "$",
"url": "https://cordis.com"
},
{
"@id": "#creator",
"@type": "Organization"
},
{
"@type": "BreadcrumbList",
"description": "Breadcrumbs list",
"itemListElement": [
{
"@type": "ListItem",
"item": "https://cordis.com/na",
"name": "Select a Region",
"position": 1
}
],
"name": "Breadcrumbs"
}
]
}
/emea/home/
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebSite",
"author": {
"@id": "https://cordis.com#identity"
},
"copyrightHolder": {
"@id": "https://cordis.com#identity"
},
"copyrightYear": "2020",
"creator": {
"@id": "https://cordis.com#creator"
},
"dateModified": "2026-04-01T10:56:20-07:00",
"datePublished": "2020-06-01T14:00:00-07:00",
"description": "Innovating and Delivering New Technologies Cordis is proud to have completed the acquisition of MedAlliance and its novel SELUTION SLR™ Drug-Eluting Balloon (DEB). Please contact your local representative for additional information Highlights SELUTION SLR PTCA Drug Eluting Balloon The SELUTION SLR™ Drug Eluting Balloon (DEB) is the latest generation of drug-eluting balloon technology designed to Go Beyond Metal and deliver consistent and predictable drug release as best-in-class drug-eluting stents RAIN Sheath Transradial Thin-walled Introducer The RAIN Sheath™ Transradial Thin-walled Introducer brings innovation in your hands with KINK RECOVERY TECHNOLOGY ™.",
"headline": "Home",
"image": {
"@type": "ImageObject",
"url": "https://cordis.com/uploads/images/_1200x630_crop_center-center_82_none/cordis-logo-black.jpg?mtime=1710771858"
},
"inLanguage": "en-us",
"mainEntityOfPage": "https://cordis.com/emea/home",
"name": "Home",
"publisher": {
"@id": "https://cordis.com#creator"
},
"url": "https://cordis.com/emea/home"
},
{
"@id": "https://cordis.com#identity",
"@type": "LocalBusiness",
"name": "Cordis",
"priceRange": "$",
"url": "https://cordis.com"
},
{
"@id": "#creator",
"@type": "Organization"
},
{
"@type": "BreadcrumbList",
"description": "Breadcrumbs list",
"itemListElement": [
{
"@type": "ListItem",
"item": "https://cordis.com/emea",
"name": "Select a Region",
"position": 1
},
{
"@type": "ListItem",
"item": "https://cordis.com/emea/home",
"name": "Home",
"position": 2
}
],
"name": "Breadcrumbs"
}
]
}
/latam/home/
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebSite",
"author": {
"@id": "https://cordis.com#identity"
},
"copyrightHolder": {
"@id": "https://cordis.com#identity"
},
"copyrightYear": "2020",
"creator": {
"@id": "https://cordis.com#creator"
},
"dateModified": "2026-04-01T10:57:52-07:00",
"datePublished": "2020-06-01T14:00:00-07:00",
"description": "Innovating and Delivering New Technologies Cordis is proud to have completed the acquisition of MedAlliance and its novel SELUTION SLR™ Drug-Eluting Balloon (DEB). Please contact your local representative for additional information Highlights RAIN Sheath™ Transradial Thin-walled Introducer The RAIN Sheath Transradial Thin-walled Introducer introduces innovation in your hands with KINK RECOVERY TECHNOLOGY ™. This system features a smaller access profile than any radial sheath, and compatibility with a variety of guiding catheters.",
"headline": "Home",
"image": {
"@type": "ImageObject",
"url": "https://cordis.com/uploads/images/_1200x630_crop_center-center_82_none/cordis-logo-black.jpg?mtime=1710771858"
},
"inLanguage": "en-us",
"mainEntityOfPage": "https://cordis.com/latam/home",
"name": "Home",
"publisher": {
"@id": "https://cordis.com#creator"
},
"url": "https://cordis.com/latam/home"
},
{
"@id": "https://cordis.com#identity",
"@type": "LocalBusiness",
"name": "Cordis",
"priceRange": "$",
"url": "https://cordis.com"
},
{
"@id": "#creator",
"@type": "Organization"
},
{
"@type": "BreadcrumbList",
"description": "Breadcrumbs list",
"itemListElement": [
{
"@type": "ListItem",
"item": "https://cordis.com/latam",
"name": "Select a Region",
"position": 1
},
{
"@type": "ListItem",
"item": "https://cordis.com/latam/home",
"name": "Home",
"position": 2
}
],
"name": "Breadcrumbs"
}
]
}
/apac/home/
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebSite",
"author": {
"@id": "https://cordis.com#identity"
},
"copyrightHolder": {
"@id": "https://cordis.com#identity"
},
"copyrightYear": "2020",
"creator": {
"@id": "https://cordis.com#creator"
},
"dateModified": "2026-04-01T10:57:09-07:00",
"datePublished": "2020-06-01T14:00:00-07:00",
"description": "Highlights RAIN Sheath™ Transradial Thin-walled Introducer The RAIN Sheath™ Transradial Thin-walled Introducer introduces innovation in your hands with KINK RECOVERY TECHNOLOGY ™.",
"headline": "Home",
"image": {
"@type": "ImageObject",
"url": "https://cordis.com/uploads/images/_1200x630_crop_center-center_82_none/cordis-logo-black.jpg?mtime=1710771858"
},
"inLanguage": "en-us",
"mainEntityOfPage": "https://cordis.com/apac/home",
"name": "Home",
"publisher": {
"@id": "https://cordis.com#creator"
},
"url": "https://cordis.com/apac/home"
},
{
"@id": "https://cordis.com#identity",
"@type": "LocalBusiness",
"name": "Cordis",
"priceRange": "$",
"url": "https://cordis.com"
},
{
"@id": "#creator",
"@type": "Organization"
},
{
"@type": "BreadcrumbList",
"description": "Breadcrumbs list",
"itemListElement": [
{
"@type": "ListItem",
"item": "https://cordis.com/apac",
"name": "Select a Region",
"position": 1
},
{
"@type": "ListItem",
"item": "https://cordis.com/apac/home",
"name": "Home",
"position": 2
}
],
"name": "Breadcrumbs"
}
]
}
Your Diagnosis
Before revealing the machine’s verdict, predict the BS score for each signal. Higher = more BS (more fluff, less verifiable substance). Drag each slider, then submit to compare your judgment against the engine.
Stuck? Reveal the heuristic lens — how the deterministic page-auditor reads each signal (no AI, pure pattern rules)
These are the structural rules a local, deterministic auditor applies — the same lens you can use to judge each signal. They describe what to look for, not this company’s result.
Classify each sentence as substantive or hollow. Grounding markers — numbers, currencies, dates, technical units, named entities — outweigh marketing adjectives. When fluff sits right next to hard evidence, the fluff is forgiven.
Pull the main entities out of the H1, then check whether they actually recur through the body. A page that announces one thing and then talks about another drifts. Headings with no real sentences underneath read as pseudo-substance.
Count trust words (review, testimonial, rating, verified) against real outbound proof links (Google, Trustpilot, Clutch, G2, Yelp). Lots of trust language with zero verification links is trust theatre. Unlinked logo galleries count against it.
Look at how much sentence length varies. Natural writing varies its rhythm; templated or mass-produced copy is statistically uniform. Very low variation reads as commodity content — unless unique named entities break the pattern.
Inspect the JSON-LD. Is there an Organization or Person schema, and does it carry sameAs links to real external profiles (LinkedIn, socials)? Missing schema or no identity declaration signals an anonymous entity.
Want to apply this lens yourself? The free BS Indicator Chrome extension runs these heuristic checks live on any page. Bear in mind it is a single-page, deterministic tool — it relies only on pattern rules for the page in front of it and does not perform the cross-page semantic correlation this audit uses, so its readout is a starting lens, not the full verdict.
Based on 745 businesses audited.
Cordis has 5.3 points less BS than the average for Medical Devices, Pharma & Biotech.
Medical Devices, Pharma & Biotech BS: Cordis (cordis.com)
Cordis delivers a high-substance medical device catalog wrapped in a thin, generic corporate shell. The site is medically credible but digitally lazy, relying on technical specifications to carry the weight of its ‘innovative’ claims while using an outdated schema identity.
Immediately upgrade the JSON-LD schema from LocalBusiness to Organization to reflect global status. Replace the generic ‘Driven by mission’ block with a ‘Clinical Evidence’ section that links directly to ClinicalTrials.gov identifiers. Add specific ISO 13485 certification details to the footer to satisfy proof expectations. Transform the ‘Need Help?’ template section into a specific ‘Technical and Clinical Support’ portal with named contacts or departments.
The site strongly matches the Medical Devices industry. The presence of specific technical terms like PTCA, Drug-Eluting Balloons, and transradial introducers, alongside mentions of clinical trials (SELUTION4ISR), confirms high alignment with cardiovascular medical technology.
“The score of 35 is driven primarily by technical substance in the product descriptions, which offsets the points gained from generic corporate cliches. The Trust and Proof pillar and Identity and Authority pillar were the largest contributors to the BS score due to the poor schema implementation and the use of unverified internal review counts.”
This training module utilizes a snapshot of public data from Cordis, captured on May 26, 2026, to demonstrate how machine logic evaluates different types of business narratives.
Purpose: This data is presented under “Fair Use” / “Educational Exception” for the purpose of forensic semantic analysis, allowing users to compare human intuition against machine-generated evaluations.
Notice to Cordis: This analysis is part of a non-adversarial audit conducted by 1 Euro SEO. The results provided by 1EuroSEO are intended as professional feedback to help improve any website’s machine-readability and authority signals. The 1EuroSEO BS Detection Tool is a free tool, and anyone can test any company to see how their content is interpreted by AI models.
Any company can use the insights for free and improve its voice by comparing it to industry clichés or competitors. When a company has updated its content, it can always submit a new audit request, which will be reflected in a new current score.
To all users: You are encouraged to visit the live site at https://cordis.com to view the most current version of its content and learn from the source what this company is about and what it offers.